NME1 and breast carcinoma: An inverse relationship between metastatic potential and NME1 expression has been reported in several types of cancers, including non-small cell lung cancer [5,6], melanoma [7], breast cancer [8], hepatocellular carcinoma [9], gastric cancer [10], and colorectal cancer [11].